Gastric-protective fragment
Also known as: BPC 157 · Body protection compound 157
The essentials at a glance
Studied preclinically for gastrointestinal tissue and wound repair; clinical benefit and safety are unproven.
Distinction: BPC-157 is derived from a gastric-protective protein, distinguishing it from thymosin beta-4-related fragments such as TB-500.
Prohibited or covered under WADA rules in competitive sport.
Available data come mostly from animal or cell models; robust human efficacy and safety data are lacking.
Not FDA/EMA approved: No FDA- or EMA-approved medicinal product; efficacy and safety are not established.
Research questions
Researchers study how a fragment derived from a gastric-protective protein affects stomach lining healing and tissue repair in models. Measures include ulcer size and healing speed in animal models.
This studies how a peptide influences the migration of cells toward an injury site, similar to workers rushing to a construction site. Speed and extent of cell migration are measured in lab models.
Researchers use controlled wound or injury models in cells or animals to study how quickly and completely tissue heals after damage. Measures typically include wound size over time and markers of new tissue formation, similar to photographing a cut each day to see how fast it closes.
Simple example
Think of it like a single sentence taken from a whole book: it carries part of the meaning, but not the whole story.
An isolated fragment can behave biologically differently than it would within the original protein, similar to how a sentence out of context can be misunderstood.
Community themes
Personal experience reports and vendor marketing from communities are not scientific proof of efficacy.
People report perceived faster healing of injuries or tendon problems after using certain peptides, usually without a control group or objective measurement. Such individual reports do not establish actual efficacy or safety.
People report subjectively perceived digestive improvements after using gastric-protective or immune-modulating peptides, usually without objective diagnostics. Such self-observations do not establish a confirmed effect on the gut.
Personal recovery times after sports injuries while using different repair peptides are compared, often based on subjective pain scales. Such individual courses are influenced by many other factors and do not prove efficacy.
Why individual profiles do not contain mixing instructions
Reconstitution depends on the exact product, label, identity, concentration, sterility and stability. Arithmetic examples appear only in the separately labelled community area and are not recommendations.
Reconstitution & quantitiesOpen basics, units and sourcesUse & mixingEvidence boundary
Evidence is mostly preclinical; human efficacy is not established.
No peptide sales or individual recommendations. A separately labelled community area documents third-party protocol claims without medically endorsing them.
Primary sources
Regulators, trial registries and scientific databases support the classification and carry more weight than vendor or community claims.
